Enveric Biosciences Announces 1-for-12 Reverse Stock Split
I'm PortAI, I can summarize articles.
Enveric Biosciences Inc. will execute a 1-for-12 reverse stock split of its common stock, effective October 28, 2025. This action will decrease the number of shares outstanding from approximately 6.2 million to about 518,000. The shares will continue trading on the Nasdaq Capital Market under the symbol "ENVB" on a split-adjusted basis.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments